INSIGHTS ON DRUG DEVELOPMENT
-
![Spray Drying With A Buchi-B290]( "Spray Drying With A Buchi-B290")
Spray Drying With A Buchi-B290Dr. Jordan Potts demonstrates how the Buchi B‑290 spray dryer works and explains its use in spray drying and particle engineering research.
-
![assessing ta webinar thumb]( "Assessing Production And Stability Of Antibody Drug Conjugate Platforms")
Assessing Production And Stability Of Antibody Drug Conjugate PlatformsADCs with similar antibody sequences can behave differently due to linker and payload choices. Analytical tools reveal structural and stability differences critical to therapeutic performance.
-
![mRNA GettyImages-1428646288]( "Advanced Therapies Going Mainstream: Are We There Yet?")
Advanced Therapies Going Mainstream: Are We There Yet?Advanced therapies are nearing mainstream adoption, with cell, mRNA, and oligonucleotide treatments expanding into broader indications. Learn what’s driving this shift and what manufacturers must do.
-
![GettyImages-1371704947-microscope-imaging-computer-cells]( "Multiplex Imaging")
Multiplex ImagingExplore recombinant antibody reagents that support the imaging of key targets within the TME and offer flexible solutions across various platforms to improve patient outcomes.
-
Eliminate Risk From Your Viral Vector Tech Transfers12/5/2025
Explore strategies to simplify viral vector tech transfers, reduce risk, and maintain quality under tight timelines, as well as a case study that demonstrates how to streamline this critical process.
-
Transforming Research Through Lab Automation7/6/2026
Self-driving labs bring automation and AI together to transform research. Learn about how continuous experimentation and real-time learning unlock faster insights and more efficient paths to innovation.
-
Neuroinflammation In Alzheimer's Disease Pathway3/24/2025
Recent research highlights neuroinflammation's role in AD progression, which suggests immune modulation as a potential therapeutic strategy. Learn more about neuroinflammatory processes in AD pathology.
-
How Lipid Nanoparticles Enable Next-Gen Delivery10/20/2025
Cell therapy’s future depends on smarter gene delivery. Learn how lipid nanoparticles offer a scalable, cell-friendly alternative to electroporation and viral vectors for manufacturing efficiency.
-
New Approach Methodologies: The Future Of Toxicology And Safety Testing6/25/2026
NAMs are transforming toxicology with human-relevant, non-animal approaches. Learn what defines a NAM, how these methods work together, and why adoption is rapidly accelerating.
DRUG DEVELOPMENT SOLUTIONS
-
![Chip-S1]( "Complete Organ-Chip Solutions To Fast-Track Your Drug Discovery")
From cancer models to high-throughput screening, Organ-Chip platforms accelerate development, improve safety, and support regulatory compliance for next-generation therapies.
-
![GettyImages-1027587952-nurse-doctor-patient-comfort]( "Molecule To Cure. Fast.")
Everything we do for our customers is driven by an unswerving belief that ideas need to become solutions, molecules need to become cures, fast. Because humanity needs solutions, fast.
-
![Contract Research Services]( "Contract Research Services For Drug Discovery And Development")
Understand and predict human response earlier in the drug development process, and harness the advantages of Organ-on-a-Chip technology without needing to invest in capital equipment or train personnel.
-
![Danaher-SCIEX]( "RNA 9000 Purity & Integrity Kit")
Easily analyze a diverse array of RNA species, from 50-9,000 bases, and achieve high-resolution data with a purity & integrity kit.
-
![AccuSEQ]( "From Process Development To QC—Optimize Your mAbs Workflow")
See how integrated analytical capabilities help improve visibility across mAb workflows, enabling faster decisions, stronger process control, and reliable quality outcomes from development through QC.
